S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) is a new skin numbing cream made of lidocaine and tetracaine. The purpose of this study is to evaluate and measure the length of time the S-Caine Peel numbs the skin, when applied for 30 and 60 minutes.

Condition	Treatment or Intervention	Phase
Pain	Drug: S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)	Phase III

Further Study Details: 

Primary Outcomes: To evaluate the duration of anesthetic effect produced by S-Caine Peel when applied for 30 and 60 minutes
Secondary Outcomes: To monitor the nature and frequency of adverse events (AEs) associated with the application of S-Caine Peel
Expected Total Enrollment:  40

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

• Subject is 18 years of age or older.
• Meet pinprick test requirements.

Exclusion Criteria:

• Subject is pregnant or breastfeeding.
• Subject has participated in a clinical trial of an unapproved drug within the previous 30 days.

Please refer to this study by ClinicalTrials.gov identifier  NCT00110253

Study ID Numbers:  SCP-44-05
Record last reviewed:  May 2005
Last Updated:  May 12, 2005
Record first received:  May 4, 2005
ClinicalTrials.gov Identifier:  NCT00110253
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-05-17